Putnam Biorevolution ETFSYNBETF
13F holders, Q4 2024 (December 31)4holders
0new positions
0sold out
$29.57avg. 13F price*
At the end of Q4 2024, 4 institutions reported holding Putnam Biorevolution ETF (SYNB) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holders were Franklin Resources Inc. ($3.7M), Royal Bank of Canada ($134K) and UBS Group AG ($325).
- Company
- Putnam Biorevolution ETF
- CUSIP
- 746729805
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 390 shares sold, net −390 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Franklin Resources Inc. | 0.00% | No change | 125,000 | $3.7M |
| Royal Bank of Canada | 0.00% | Reduce -8.0% | 4,518 | $134K |
| UBS Group AG | 0.00% | No change | 11 | $325 |
| Osaic Holdings, Inc. | 0.00% | No change | 2 | $59 |
"% of holder's portfolio" is SYNB's weight in each manager's 13F, not the share of Putnam Biorevolution ETF the manager owns.